Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin dministration

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 203-211

  Michiels, Marie José ^b   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; FIBRIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; FIBRIN CLOT; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; BLOOD COAGULATION; COLONY COUNT, MICROBIAL; DAPTOMYCIN; FEMALE; FIBRIN; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; RABBITS; STAPHYLOCOCCUS;

EID: 0030030306     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.203     Document Type: Article

References (30)

1. Alborn, W. E., Jr., N. E. Allen, and D. A. Preston. 1991 Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother 35:2282-2287.
2. Allen, N. E., W. E. Alborn, Jr., and J. N. Hobbs, Jr. 1991. Inhibition of membrane potential-dependent amino acid transport by daptomycin. Antimicrob Agents Chemother. 5:2639-2642.
3. Bayer, A. S., D. Gavell, C. C. Nast, D. C. Norman, and R. L. Borrelli. 1990. Intraaortic antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment. Chest 97:611-617.
4. Bergeron, M. G., and L. Brousseau. 1986 Tissue fluid pharmacokinetic models in humans and animals. p. 71-107. In O. Zak and M A. Sande (ed.). Experimental models in antimicrobial chemotherapy, vol. 1. Academic Press. Inc. (London) Ltd , London.
5. Bergeron, M. G., J. Robert, and D. Beauchamp. 1993. Pharmacodynamics of antibiotics in fibrin clots J. Antimicrob Chemother. 31(Suppl D):113-136
6. Chhatwal, G. S., K. T. Preissner, G. Müller-Berghaus, and II. Blobel. 1987. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coll. Infect. Immun 55:1878-1883.
7. Crémieux, A. C., B. Maziere, J. M. Vallois, M. Ottaviani, A. Azancot, H. Raffoul, A. Bouvet, J. J. Pocidalo, and C. Carbon. 1989. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography J. Infect Dis 159:938-944.
8. De La Maza, L., K. L. Ruoff, and M. R. Ferraro. 1989. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria, Antimicrob. Agents Chemother. 33:1383-1384.
9. Eliopoulos, G. M., S. Willey, E. A. Reiszner, P. G. Spitzer, G. Caputo, and R. S. Moellering, Jr. 1986. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic Antimicrob. Agents Chemother. 30:532-535
10. Friedman, M. 1938. A study of the fibrin factor in relation to subacute endocarditis. J. Pharmacol. Exp Ther. 63:173-182.
11. Garrison, M. W., K. Vance-Bryan, T. A. Larson, J. P. Toscane, and J. C. Rotschafer. 1990. Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 34:1925-1931.
12. Hamill, R. J. 1987. Role of fibronectin in infective endocarditis. Rev. Infect. Dis. 9(Suppl. 4):S360-S371.
13. 2- and albumin on these drugs. Antimicrob. Agents Chemother. 35:1710-1716.
14. Hawiger, J., S. Timmons, D. D. Strong, D. A. Cottreill, M. Riley, and R. F. Doolittle. 1982. Identification of a region of human interaction with staphylococcal clumping factor. Biochemistry 21:1407-1413.
15. Herrmann, M., Q. J. Lai, R. M. Albrecht, D. F. Mosher, and R. A. Proctor. 1993 Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J. Infect. Dis 167:312-322.
16. Herrmann, M., S. J. Suchard, L. A. Boxer, F. A. Waldvogel, and P. D. Lew. 1991. Thrombospondin binds to Siaphylococcus aureus and promotes staphylococcal adherence to surfaces Infect. Immun. 59:279-288.
17. Lamp, K. C., M. J. Rybak, E. M. Bailey, and G. W. Kaatz. 1992 In vitro pharmacodynamic effects of concentration, pH. and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob. Agents Chemother. 36:2709-2714
18. Lee, B. L., M. Sachdeva, and H. F. Chambers. 1991. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrob. Agents Chemother 35:2505 2508
19. Nathanson, M. H., and R. A. Liebhold. 1946. Diffusion of sulfonamides and penicillin into fibrin. Proc. Soc. Exp. Biol Med. 62:83-86.
20. O'Connel, C. J., and M. E. Plaut. 1969. Fibrin penetration by penicillin: in vitro stimulation of intravenous therapy. J. Lab. Clin. Med. 73:258-265.
21. Raad, I., J. Narro, A. Khan, S. Vartivarian, and G. P. Bodey. 1992. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 11:675-682
22. Rotstein, O. D. 1992. Role of fibrin deposition in the pathogenesis of intraabdominal infection. Eur. J. Clin. Microbiol. Infect. Dis. 11:1064-1068.
23. Rybak, M. J., E. M. Bailey, K. C. Lamp, and G. W. Kaatz. 1992. Pharmacokinetics and bacterial rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia. Antimicrob. Agents Chemother. 36:1109-1114.
24. Sahm, D. F., and A. J. Washington. 1991 Antibacterial susceptibility tests: dilution methods, p. 1108-1111. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
25. Shonekan, D., D. Mildvan, and S. Handwerger. 1992. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD 127,391 against blood isolates of gram-positive cocci. Antimicrob. Agents Chemother. 36:1570-1572.
26. Tornos, M.-P., G. Permanyer-Miralda, M. Olona, M. Gil, E. Galve, B. Almirante, and J. Soler-Soler. 1992. Long-term complications of native valve infective endocarditis in non-addicts a 15-year follow-up study. Ann. Intern. Med 117:567-572.
27. Turcotte, A., and M. G. Bergeron. 1992. Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots. Antimicrob. Agents Chemother. 36:2211-2215.
28. Vaudaux, P., D. Pittet, A. Haeberli, E. Huggler, U. E. Nydegger, P. D. Lew, and F. A. Waldvogel. 1989. Host factors selectively increase staphylococcal adherence on inserted catheters: a role of fibronectin and fibrinogen or fibrin J. Infect. Dis. 160:865-875.
29. Vercellotti, G. M., J. B. McCarthy, P. Lindhom, P. K. Peterson, H. S. Jacob, and L. T. Furcht. 1985 Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggiegate bacteria. Am. J Pathol. 120:13-21.
30. Weinstein, L., G. K. Daikos, and T. S. Perrin. 1951. Studies on the relationship of tissue fluid and blood levels of penicillin. J Lab. Clin. Med. 38: 712-718.